These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6153207)

  • 1. A simple immunofluorescence assay for C1q binding.
    Linder E
    J Immunol Methods; 1980; 32(3):239-49. PubMed ID: 6153207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement fixing antibodies to DS-DNA in systemic lupus erythematosus: a study using the immunofluorescent Crithidia luciliae method.
    Beaulieu A; Quismorio FP; kitridou RC; Friou GJ
    J Rheumatol; 1979; 6(4):389-96. PubMed ID: 392093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of fibronectin to DNA: new application of the Crithidia luciliae immunofluorescence test.
    Cseh K; Jakab L; Török J; Kalabay L; Pozsonyi T
    Acta Microbiol Hung; 1985; 32(2):175-82. PubMed ID: 3904305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
    Heinz HP; Burger R; Golan MD; Loos M
    J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-independent activation of C1, the first component of complement.
    Loos M
    Ann Immunol (Paris); 1982; 133C(2):165-79. PubMed ID: 6287904
    [No Abstract]   [Full Text] [Related]  

  • 6. Reappraisal of the specificity of the Crithidia luciliae assay for nDNA antibodies: evidence for histone antibody kinetoplast binding.
    Deng JS; Rubin RL; Lipscomb MF; Sontheimer RD; Gilliam JN
    Am J Clin Pathol; 1984 Oct; 82(4):448-52. PubMed ID: 6383014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The Crithidia luciliae immunofluorescence test for detection of antibodies to double-stranded DNA (author's transl)].
    Herzer P; Greif G; Lemmel EM
    Klin Wochenschr; 1982 Feb; 60(3):143-51. PubMed ID: 7043069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The classical complement pathway: activation and regulation of the first complement component.
    Cooper NR
    Adv Immunol; 1985; 37():151-216. PubMed ID: 3890478
    [No Abstract]   [Full Text] [Related]  

  • 9. Specificity of the hydrochloric-acid-modified Crithidia luciliae immunofluorescence assay for detection of antibody to native DNA.
    Henderson T; Medsger TA; Sontheimer RD; Harmon CE; Deng JS
    Diagn Clin Immunol; 1987; 5(1):20-4. PubMed ID: 3297382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reevaluation of specificity of Crithidia luciliae kinetoplast as a substrate for detecting antibodies to double-stranded deoxyribonucleic acid.
    Steinmetz SE; Deng JS; Rubin RL; Sontheimer RD; Gilliam JN
    J Am Acad Dermatol; 1984 Sep; 11(3):490-3. PubMed ID: 6384293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of C1q subcomponent with immunoglobulin M.
    Kimak E; Tomaszewski JJ
    Acta Biochim Pol; 1986; 33(3):179-85. PubMed ID: 2433858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement-fixing antibodies to dsDNA detected by the immunofluorescence technique on Crithidia luciliae. A critical appraisal.
    Esparza RH; Swaak T; Aarden L; Smeenk R
    J Rheumatol; 1985 Dec; 12(6):1109-17. PubMed ID: 3912506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Levels of anti-nDNA using immunofluorescence on Crithidia luciliae. II. Prognostic value of complement-fixing anti-nDNA. Longitudinal study of 16 lupus disorders].
    Meyer O; Borda-Iriarte O; Cyna J; Haïm T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1984 May; 51(5):243-9. PubMed ID: 6377460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1q binding and C1 activation by various isolated cellular membranes.
    Storrs SB; Kolb WP; Olson MS
    J Immunol; 1983 Jul; 131(1):416-22. PubMed ID: 6602834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunofluorescence on Crithidia luciliae in the detection of anti-native DNA antibodies (author's transl)].
    André C; Villeminot S; Bourhala S
    Nouv Presse Med; 1982 Apr; 11(15):1127-30. PubMed ID: 7043393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunofluorescence assay for complement activation by the classical pathway.
    Linder E; Rhen M; Meri S
    J Immunol Methods; 1981; 47(1):49-59. PubMed ID: 7031140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The binding of antihistone antibodies to Crithidia luciliae kinetoplasts is growth cycle-dependent.
    Deng JS; Sontheimer RD; Lipscomb MF; Gilliam JN
    Arthritis Rheum; 1985 Feb; 28(2):163-8. PubMed ID: 3970731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of commercial kits for the detection of anti-nDNA antibodies using Crithidia luciliae.
    Jansen EM; Deng JS; Beutner EH; Kumar V; Chorzelski TP
    Am J Clin Pathol; 1987 Apr; 87(4):461-9. PubMed ID: 3548319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-independent activation of C1, the first component of complement, by cardiolipin.
    Kovacsovics T; Tschopp J; Kress A; Isliker H
    J Immunol; 1985 Oct; 135(4):2695-700. PubMed ID: 4031497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.